Neuberger Berman Group
GILD icon

Neuberger Berman Group’s Gilead Sciences GILD Stock Holding History

Neuberger Berman Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$186M Sell
1,331,058
-28,386
-2% -$3.98M 0.14% 161
2025
Q4 		$167M Sell
1,359,444
-223,999
-14% -$27.2M 0.12% 193
2025
Q3 		$176M Sell
1,583,443
-252,597
-14% -$28.7M 0.13% 192
2025
Q2 		$204M Buy
1,836,040
+950,032
+107% +$101M 0.16% 152
2025
Q1 		$99.3M Buy
886,008
+580,212
+190% +$59.9M 0.08% 293
2024
Q4 		$28.2M Buy
305,796
+77,773
+34% +$7M 0.02% 577
2024
Q3 		$19.1M Sell
228,023
-11,675
-5% -$891K 0.01% 666
2024
Q2 		$16.4M Sell
239,698
-724,985
-75% -$48.4M 0.01% 682
2024
Q1 		$70.6M Sell
964,683
-4,599,385
-83% -$354M 0.06% 351
2023
Q4 		$451M Buy
5,564,068
+2,213,739
+66% +$172M 0.39% 55
2023
Q3 		$251M Buy
3,350,329
+232,409
+7% +$17.9M 0.23% 110
2023
Q2 		$240M Buy
3,117,920
+308,752
+11% +$24.6M 0.21% 125
2023
Q1 		$233M Buy
2,809,168
+2,591,625
+1,191% +$215M 0.22% 130
2022
Q4 		$18.7M Buy
217,543
+37,833
+21% +$3M 0.02% 627
2022
Q3 		$11.1M Sell
179,710
-157,256
-47% -$9.92M 0.01% 715
2022
Q2 		$20.9M Sell
336,966
-1,310,247
-80% -$81.1M 0.02% 615
2022
Q1 		$97.9M Buy
1,647,213
+1,404,088
+578% +$89.8M 0.08% 316
2021
Q4 		$16.5M Buy
243,125
+54,429
+29% +$3.75M 0.01% 732
2021
Q3 		$12.6M Buy
188,696
+7,966
+4% +$560K 0.01% 773
2021
Q2 		$12.1M Buy
180,730
+11,673
+7% +$779K 0.01% 790
2021
Q1 		$10.7M Sell
169,057
-1,362,582
-89% -$87.9M 0.01% 811
2020
Q4 		$89.2M Buy
1,531,639
+134,094
+10% +$8.09M 0.09% 291
2020
Q3 		$88.3M Buy
1,397,545
+31,597
+2% +$2.19M 0.1% 263
2020
Q2 		$105M Buy
1,365,948
+133,371
+11% +$10.2M 0.13% 213
2020
Q1 		$92.2M Sell
1,232,577
-2,203,856
-64% -$152M 0.14% 197
2019
Q4 		$223M Sell
3,436,433
-293,109
-8% -$19.1M 0.26% 100
2019
Q3 		$236M Sell
3,729,542
-148,087
-4% -$9.68M 0.29% 91
2019
Q2 		$262M Buy
3,877,629
+183,902
+5% +$12.1M 0.31% 74
2019
Q1 		$240M Buy
3,693,727
+367,209
+11% +$24.4M 0.29% 81
2018
Q4 		$208M Sell
3,326,518
-71,811
-2% -$5.02M 0.29% 80
2018
Q3 		$262M Sell
3,398,329
-517,324
-13% -$39.1M 0.3% 73
2018
Q2 		$277M Buy
3,915,653
+654,557
+20% +$46.2M 0.31% 74
2018
Q1 		$246M Buy
3,261,096
+179,733
+6% +$14.3M 0.28% 90
2017
Q4 		$221M Buy
3,081,363
+177,436
+6% +$13.5M 0.25% 106
2017
Q3 		$235M Buy
2,903,927
+320,731
+12% +$24.5M 0.29% 88
2017
Q2 		$183M Buy
2,583,196
+1,229,916
+91% +$81.8M 0.23% 129
2017
Q1 		$91.9M Buy
1,353,280
+305,390
+29% +$21.5M 0.12% 250
2016
Q4 		$75M Buy
1,047,890
+93,691
+10% +$6.96M 0.1% 296
2016
Q3 		$75.5M Buy
954,199
+482,221
+102% +$39.2M 0.1% 289
2016
Q2 		$39.4M Buy
471,978
+8,489
+2% +$753K 0.05% 424
2016
Q1 		$42.6M Sell
463,489
-143,341
-24% -$12.9M 0.06% 403
2015
Q4 		$61.4M Buy
606,830
+75,943
+14% +$7.9M 0.08% 329
2015
Q3 		$52.1M Buy
530,887
+264,205
+99% +$29.3M 0.07% 357
2015
Q2 		$31.2M Buy
266,682
+7,456
+3% +$815K 0.03% 553
2015
Q1 		$25.4M Buy
259,226
+145,643
+128% +$14.8M 0.03% 619
2014
Q4 		$10.7M Sell
113,583
-1,232
-1% -$127K 0.01% 810
2014
Q3 		$12.2M Buy
114,815
+11,537
+11% +$1.13M 0.01% 803
2014
Q2 		$8.56M Buy
103,278
+25,307
+32% +$1.97M 0.01% 862
2014
Q1 		$5.53M Sell
77,971
-7,096
-8% -$557K 0.01% 911
2013
Q4 		$6.39M Sell
85,067
-18,641
-18% -$1.3M 0.01% 873
2013
Q3 		$6.52M Sell
103,708
-33,255
-24% -$1.99M 0.01% 862
2013
Q2 		$7.02M Buy
+136,963
New +$7.14M 0.01% 828

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group's GILD Position: Q1 2026 in Review

Neuberger Berman Group reduced its Gilead Sciences (GILD) stake by 2.1% in Q1 2026, selling an estimated $3.98M and leaving 1,331,058 shares worth $186M. The position accounts for 0.14% of the portfolio, ranked #161.

Neuberger Berman Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $451M in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Neuberger Berman Group held 1,331,058 shares of Gilead Sciences worth $186M as of Q1 2026.
  • Neuberger Berman Group sold 28,386 Gilead Sciences shares in Q1 2026, an estimated $3.98M.
  • Gilead Sciences made up 0.14% of Neuberger Berman Group's portfolio in Q1 2026, its #161 holding.
  • Neuberger Berman Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's Gilead Sciences position peaked at $451M in Q4 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.